Security key
019770106
Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO)
CUSIP: 019770106
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share (the "Shares")
- Total 13F shares
- 164,371,652
- Total 13F value
- $460,365,265
- Share change
- -1,761,792
- Put/Call ratio
- 191%
- SEC-reported price per share
- $2.80
- Number of holders
- 152
- Value change
- -$1,917,859
- Number of buys
- 66
- Number of sells
- 72
- Shares outstanding
- 244,825,714
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
152
Top holders
10
ALLO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Allogene Therapeutics, Inc. SEC filings
Allogene Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 019770106
Recent filing periods:
Ownership snapshot
Top reported holders of ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
13%
TPG GP A, LLC
7.6%
BlackRock Finance, Inc.
6.7%
VANGUARD GROUP INC
3.3%
STATE STREET CORP
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
13%
|
$72,830,208
31,257,600 shares
|
— | 30 Jun 2024 |
| TPG GP A, LLC |
3/4/5
13F
10%+ Owner · Company
|
7.6%
from 13F
|
$59,413,042
18,716,306 shares
|
— | 12 Jan 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
6.7%
|
$38,318,438
16,445,682 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.3%
|
$19,095,902
8,195,666 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
3.1%
|
$17,866,729
7,668,124 shares
|
— | 30 Jun 2024 |
| Capital World Investors |
13F
Company
|
2.8%
|
$16,068,966
6,896,552 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
152
Shares
164,371,652
Rows available
152
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
169
Q3 2024 holders
152
Holder diff
-17
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend